Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer

por Wang, Chongkai, Chevalier, Dawnyel, Saluja, Janelle, Sandhu, Jaideep, Lau, Cecilia, Fakih, Marwan
Publicado 2020